Resistance Rising: How Drug-Resistant Tuberculosis Is Rewriting the Rules of American Public Health
Multidrug-resistant tuberculosis is no longer a distant global concern—it is quietly reshaping clinical protocols, straining healthcare budgets, and challenging the foundational assumptions of TB management across the United States. As resistance patterns grow more complex, infectious disease specialists are confronting a disease that increasingly defies the treatment tools built to contain it. This investigation examines the science, the patients, and the systemic pressures behind one of public